Status:
COMPLETED
Validation of Handheld Ultrasound Devices in Rheumatology
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
University of Florida
University Health Network, Toronto
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joi...
Detailed Description
This study is a clinical trial testing the concurrent validity of Clarius handheld ultrasound devices against the gold-standard device to detect characteristics (i.e., anatomical structures and vascul...
Eligibility Criteria
Inclusion
- Age ≥18
- Meets the classification for psoriatic arthritis (CASPAR) criteria
- Able to provide an informed consent
- Having peripheral disease phenotype of PsA
- At least one tender and swollen join on the day of US
Exclusion
- Having isolated axial PsA
- Being in MDA with no tender and swollen joints
Key Trial Info
Start Date :
January 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 28 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06580886
Start Date
January 16 2023
End Date
June 28 2024
Last Update
August 30 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida College of Medicine
Gainesville, Florida, United States, 32610
2
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada, K1H 8L6
3
Women's College Research Institute
Toronto, Ontario, Canada, M5S 1B2